US37940X1028 - Common Stock
100.87 -1.04 (-1.02%)
After market: 100.87 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-06-05 | Susquehanna | Maintains | Positive -> Positive |
2023-05-05 | Evercore ISI Group | Reiterate | In-Line |
2023-05-04 | Mizuho | Maintains | Neutral |
2023-05-02 | Keefe, Bruyette & Woods | Maintains | Outperform |
2023-05-02 | Oppenheimer | Reiterate | Outperform |
2023-05-02 | RBC Capital | Reiterate | Outperform |
2023-05-02 | Stephens & Co. | Reiterate | Overweight |
2023-05-02 | Raymond James | Maintains | Outperform |
2023-05-02 | Credit Suisse | Maintains | Neutral |
2023-04-28 | Citigroup | Reiterate | Buy |
2023-04-24 | Keybanc | Maintains | Overweight |
2023-04-19 | Oppenheimer | Maintains | Outperform |
2023-04-19 | Baird | Upgrade | Neutral -> Outperform |
2023-04-18 | JP Morgan | Downgrade | Overweight -> Neutral |
2023-04-12 | Goldman Sachs | Upgrade | Neutral -> Buy |
2023-02-27 | Mizuho | Maintains | Neutral |
2023-02-13 | BMO Capital | Maintains | Outperform |
2023-02-13 | Stephens & Co. | Reiterate | Overweight |
2023-02-13 | Raymond James | Maintains | Outperform |
2023-02-13 | Truist Securities | Maintains | Buy |
2023-02-13 | Baird | Maintains | Neutral |
2023-02-13 | Morgan Stanley | Maintains | Overweight |
2023-01-25 | Oppenheimer | Maintains | Outperform |
2023-01-20 | Truist Securities | Maintains | Buy |
2023-01-17 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
2023-01-09 | Keybanc | Maintains | Overweight |
2023-01-09 | Wells Fargo | Maintains | Overweight |
2023-01-09 | Goldman Sachs | Maintains | Neutral |
2022-12-20 | Truist Securities | Maintains | Buy |
2022-12-15 | UBS | Maintains | Buy |
Find the competitors with the best analyst ratings on the USA